Drug information provided by: Merative, Micromedex®
SARS-CoV-2 vaccine (adenovirus 26 vector) is under investigation as an active immunization against COVID-19 caused by the SARS-CoV-2 virus in patients 18 years of age and older. SARS-CoV-2 (COVID-19) vaccine is used to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Janssen COVID-19 vaccine is used in patients for whom other authorized or approved COVID-19 vaccines are not accessible or appropriate, or in patients who elect to receive this vaccine because they would otherwise not receive a COVID-19 vaccine.
This vaccine is to be given only by or under the direct supervision of your doctor.
Portions of this document last updated: July 01, 2023